Rovetia

How Do Pediatricians Manage Fever Without a Source?

pediatrician fever-without-source clinical-assessment
Quick answer: Assess risk with the traffic light system, test by age and appearance, always check urine in under 36 months, admit and treat high-risk infants, and give a written safety net with 24 to 48 hour follow-up.

Fever is the most common reason parents consult a doctor about their child and the second most common cause of childhood hospital admission. Most fevers come from self-limiting viral infections, yet infections remain the most frequent cause of death in children under 5. The challenge with fever without an obvious source is separating the small number of children with a serious bacterial illness from the large majority who will recover on their own. A structured, age-based approach makes that distinction safer and more consistent.

Step 1: Confirm and Measure the Fever Accurately

Feverish illness in a child under 5 is defined as a temperature over 38 degrees C. How you measure it matters.

Duration and height of fever alone do not predict serious illness. An unexplained tachycardia, however, may signal serious disease such as septic shock.

Step 2: Exclude Immediate Threats and Consider Sepsis

Before any risk scoring, check the airway, breathing, and circulation for life-threatening compromise and manage it according to paediatric life support guidance. Think sepsis first. Sepsis is life-threatening organ dysfunction from a dysregulated response to infection.

As a minimum, measure and record temperature, heart rate, respiratory rate, oxygen saturation, and capillary refill time, and repeat them at least once after triage. Do not discharge a child with abnormal physiology without discussion with a senior clinician.

Step 3: Assign Risk With the Traffic Light System

The NICE traffic light system stratifies children into green, amber, and red based on five domains: colour, activity, respiratory effort, circulation and hydration, and other features. It should be applied until a clinical diagnosis is made.

Red features (high risk):

Amber features (intermediate risk): pallor reported by the parent, not responding normally to social cues, no smile, decreased activity, waking only with prolonged stimulation, nasal flaring, tachypnoea, oxygen saturation under 95 percent, crackles, tachycardia, dry mucous membranes, poor feeding in infants, capillary refill time of 3 seconds or more, reduced urine output, fever for 5 days or more, rigors, or swelling of a limb or joint.

Green features (low risk): normal colour, responds normally to social cues, content and smiles, stays awake, strong normal cry, normal skin and eyes with moist mucous membranes, and no amber or red features.

Step 4: Search for a Focus of Infection

Look for symptoms and signs of specific diseases so that targeted management can replace the generic febrile-illness pathway. Consider meningococcal disease (non-blanching rash in an ill-looking child), meningitis (neck stiffness, bulging fontanelle, decreased conscious level), pneumonia (tachypnoea, crackles, nasal flaring, chest indrawing, oxygen under 95 percent), urinary tract infection (vomiting, poor feeding, lethargy, irritability, abdominal pain, dysuria), intra-abdominal infection, septic arthritis or osteomyelitis (swollen limb, not using an extremity, non-weight-bearing), Kawasaki disease (fever for 5 days or more plus four of bilateral conjunctival injection, mucous membrane changes, extremity changes, polymorphous rash, and cervical lymphadenopathy), and imported infection if the child has travelled abroad. A proven viral respiratory illness such as RSV or influenza does not exclude a serious bacterial infection, including UTI, so these children still need assessment.

Step 5: Stratify Testing by Age and Clinical Appearance

The goal is to minimise testing without missing an invasive bacterial infection. Testing depends on age, temperature, and how the child looks.

Any toxic or seriously ill-appearing child, regardless of age or immunisation status, requires a full evaluation: complete blood count with differential, blood cultures from two separate sites, urine culture and urinalysis, lumbar puncture, and admission with empiric intravenous antibiotics.

Infants under 3 months carry the highest risk of invasive bacterial infection, historically around 8 to 10 percent and currently closer to 2 to 5 percent in infants 8 to 60 days old. A well appearance does not reliably exclude infection in this group. Current American Academy of Pediatrics guidance for well-appearing febrile infants 8 to 60 days old uses three age bands:

High-risk inflammatory markers include fever of 38 degrees C or higher, C-reactive protein over 20 mg per litre, procalcitonin over 0.5 nanograms per millilitre, and absolute neutrophil count over 4000 per microlitre when used with procalcitonin, or over 5200 per microlitre when procalcitonin is unavailable. The absolute neutrophil count is more predictive than the total white blood cell count.

Well-appearing, fully immunized children aged 3 to 36 months are now at very low risk of occult bacteremia. Conjugate vaccines have eliminated over 99 percent of Haemophilus influenzae type b infections and reduced pneumococcal invasive disease by at least 70 percent overall. In this group, obtain a urinalysis and urine culture because urinary tract infection is now the most common cause of invasive bacterial infection presenting as fever without a source. Routine blood tests, blood cultures, and chest x-rays are not indicated. When available, rapid viral testing for enterovirus, respiratory syncytial virus, and influenza in infants over 30 days can reduce further testing, because a positive result likely explains the fever. Manage the child at home, give antipyretics, and arrange follow-up by visit or telephone in 24 to 48 hours. Children who worsen or remain febrile should then have further testing.

Unimmunized, underimmunized, or immunocompromised children in the 3 to 36 month range are more susceptible to invasive bacterial infection and typically need the same full evaluation and empiric antibiotics as toxic-appearing children.

Step 6: Decide on Admission or Home Management

Use the risk category and age together with social and family circumstances, parental anxiety, contact with serious infectious disease, recent travel, and any previous family experience of serious febrile illness.

Red Flags Requiring Immediate Action

Common Questions

When should antipyretics be used?

Consider paracetamol or ibuprofen only when the child is distressed or unwell. Do not give both simultaneously, though you may try the alternative if the first does not help. Do not give antipyretics with the sole aim of reducing the temperature, and continue them only as long as the child appears distressed. Do not rely on the fever response to tell serious from non-serious illness, because an afebrile child who still looks unwell is a concern. Antipyretics do not prevent febrile convulsions.

Should every febrile child have blood tests?

No. In a well-appearing, fully immunized child aged 3 to 36 months, the risk of bacteremia is now as low as the rate of false-positive blood cultures from skin contamination. Routine complete blood counts, blood cultures, and chest x-rays are not indicated. Urinalysis and urine culture are recommended. Reserve blood cultures, inflammatory markers, and lumbar puncture for toxic-appearing, very young, unimmunized, or immunocompromised children.

What is occult bacteremia, and is it still common?

Occult bacteremia is bacteria in the bloodstream of a febrile young child who has no apparent focus of infection and looks well. Before conjugate vaccines, 3 to 5 percent of children aged 3 to 36 months with fever over 38.5 degrees C and no localising signs had it, mostly from Streptococcus pneumoniae. Routine vaccination has made it rare except in underimmunized or immunocompromised children. Urinary tract infection is now the most common invasive bacterial infection presenting as fever without a source.

How long can a fever persist before it needs more investigation?

Fever lasting 5 days or more warrants reassessment. At that point consider Kawasaki disease and PIMS-TS, and re-evaluate for a developing focus. Any febrile child under 1 year who re-attends within 72 hours of the first visit must be reviewed by a senior clinician.

Protocol Summary

How Rovetia Helps

Rovetia organises every encounter into a searchable patient timeline, so a febrile child's recorded observations, examination findings, urine and culture results, and safety-net advice stay visible across visits rather than getting lost between appointments. AI-assisted documentation from voice dictation or uploaded lab reports lets pediatricians capture the assessment quickly and focus on the child. Structured follow-up tracking makes it easier to confirm that the 24 to 48 hour revisit happened and to spot the child who re-attends within 72 hours, supporting safer continuity of care for fever without a source.

Sources

Less management, more attention

Convert scattered medical information into structured, searchable, time-saving clinical intelligence.

Get started FREE